MAPK3 and cancer: Because the ERK1/2 pathway (consisting of kinases RAS, RAF and ERK1/2) is known to activate the expression of CCND1 [32], and the hyperactivation of ERK1/2 drives cancer cell growth in various cancers [33, 34].